Boston Scientific (BSC) technology is designed to provide improved clinical outcomes and contribute to the long term viability of DBS therapy. The goal of our clinical programs is to provide clinical evidence which helps physicians translate innovations to improved patient outcomes and to partner with physicians in driving innovation and advancing patient care.

Below are the types of clinical programs we support. 

Premarket Clinical Trials

  • Support new products and indications
  • Conducted in a controlled environment


Post Market Research

  • Provide evidence for approved products and indications
  • Flexible study design for expedited data release